PT102642A - PHARMACEUTICAL PHARMACEUTICAL COMPOSITION OF DAILY UNIQUE DOSAGE CONTAINING BRIVUDINE - Google Patents

PHARMACEUTICAL PHARMACEUTICAL COMPOSITION OF DAILY UNIQUE DOSAGE CONTAINING BRIVUDINE

Info

Publication number: PT102642A
Authority: PT; Portugal
Prior art keywords: pharmaceutical; dosage containing; pharmaceutical composition; unique dosage; containing brivudine
Prior art date: 2001-01-03

Application number

PT102642A

Other languages

Portuguese (pt)

Other versions

PT102642B (en

Inventor

Alessandro Casini

Bettina Stubinski

Attilio Crea

Original Assignee

Berlin Chemie Ag

Menarini Ricerche Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-03

Filing date

2001-07-05

Publication date

2002-07-31

2001-07-05 Application filed by Berlin Chemie Ag, Menarini Ricerche Spa filed Critical Berlin Chemie Ag

2002-07-31 Publication of PT102642A publication Critical patent/PT102642A/en

2003-06-30 Publication of PT102642B publication Critical patent/PT102642B/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

PT102642A 2001-01-03 2001-07-05 PHARMACEUTICAL PHARMACEUTICAL COMPOSITION OF DAILY UNIQUE DOSAGE CONTAINING BRIVUDINE PT102642B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT2001MI000009A ITMI20010009A1 (en)	2001-01-03	2001-01-03	PHARMACEUTICAL COMPOSITIONS CONTAINING BRIVUDINA FOR SINGLE DAILY ADMINISTRATION

Publications (2)

Publication Number	Publication Date
PT102642A true PT102642A (en)	2002-07-31
PT102642B PT102642B (en)	2003-06-30

Family

ID=11446384

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT102642A PT102642B (en)	2001-01-03	2001-07-05	PHARMACEUTICAL PHARMACEUTICAL COMPOSITION OF DAILY UNIQUE DOSAGE CONTAINING BRIVUDINE

Country Status (20)

Country	Link
AT (1)	AT6141U1 (en)
BE (1)	BE1014522A5 (en)
CH (1)	CH695662A5 (en)
CZ (1)	CZ20012464A3 (en)
DK (1)	DK177084B1 (en)
ES (1)	ES2192456B1 (en)
FI (1)	FI20011446A (en)
FR (1)	FR2818907B1 (en)
GB (1)	GB2370771A (en)
GR (1)	GR1004012B (en)
HR (1)	HRPK20010345B3 (en)
HU (1)	HUP0102816A3 (en)
IE (1)	IE20010413A1 (en)
IT (1)	ITMI20010009A1 (en)
NL (1)	NL1018431C2 (en)
PL (1)	PL348480A1 (en)
PT (1)	PT102642B (en)
SE (1)	SE0102309L (en)
SK (1)	SK287043B6 (en)
UA (1)	UA76402C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2239527B1 (en) *	2004-03-01	2006-11-16	M. Cruz Fernandez Gonzalez	PHARMACOLOGICAL COMPOSITION OF TOPICAL USE FOR THE TREATMENT OF HERPES ZOSTER.
CN113712928A (en) *	2021-09-29	2021-11-30	重庆市力扬医药开发有限公司	Brivudine drug absorbed through oral mucosa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0104857A1 (en) *	1982-09-28	1984-04-04	Beecham Group Plc	Deoxyuridine compounds, methods for preparing them and their use in medicine
IT1170232B (en) *	1983-10-31	1987-06-03	Anna Gioia Stendardi	THERAPEUTIC COMPOSITIONS WITH ANTI-VIRAL ACTIVITY
US5446031A (en) *	1991-04-24	1995-08-29	Yamasa Shuyu Kabushiki Kaisha	1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
ATE254463T1 (en) *	1996-01-19	2003-12-15	Glaxo Group Ltd	USE OF VALACICLOVIR FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF GENITAL HERPES BY ONCE DAILY ADMINISTRATION

2001
- 2001-01-03 IT IT2001MI000009A patent/ITMI20010009A1/en unknown
- 2001-04-25 IE IE20010413A patent/IE20010413A1/en not_active IP Right Cessation
- 2001-05-01 GB GB0110682A patent/GB2370771A/en not_active Withdrawn
- 2001-05-11 HR HR20010345A patent/HRPK20010345B3/en not_active IP Right Cessation
- 2001-05-29 CH CH00987/01A patent/CH695662A5/en not_active IP Right Cessation
- 2001-06-28 SE SE0102309A patent/SE0102309L/en not_active Application Discontinuation
- 2001-06-29 FR FR0108596A patent/FR2818907B1/en not_active Expired - Lifetime
- 2001-06-29 DK DKPA200101019A patent/DK177084B1/en not_active IP Right Cessation
- 2001-07-02 NL NL1018431A patent/NL1018431C2/en not_active IP Right Cessation
- 2001-07-03 FI FI20011446A patent/FI20011446A/en not_active Application Discontinuation
- 2001-07-04 BE BE2001/0452A patent/BE1014522A5/en not_active IP Right Cessation
- 2001-07-04 CZ CZ20012464A patent/CZ20012464A3/en unknown
- 2001-07-04 SK SK957-2001A patent/SK287043B6/en not_active IP Right Cessation
- 2001-07-04 UA UA2001074658A patent/UA76402C2/en unknown
- 2001-07-05 ES ES200101566A patent/ES2192456B1/en not_active Expired - Fee Related
- 2001-07-05 GR GR20010100322A patent/GR1004012B/en unknown
- 2001-07-05 PL PL01348480A patent/PL348480A1/en not_active Application Discontinuation
- 2001-07-05 PT PT102642A patent/PT102642B/en active IP Right Grant
- 2001-07-05 HU HU0102816A patent/HUP0102816A3/en unknown
2002
- 2002-07-03 AT AT0805702U patent/AT6141U1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
BE1014522A5 (en)	2003-12-02
GR1004012B (en)	2002-11-01
ES2192456A1 (en)	2003-10-01
PL348480A1 (en)	2002-07-15
NL1018431C2 (en)	2002-07-05
HU0102816D0 (en)	2001-09-28
CH695662A5 (en)	2006-07-31
DK200101019A (en)	2002-07-04
UA76402C2 (en)	2006-08-15
FI20011446A (en)	2002-07-04
SE0102309D0 (en)	2001-06-28
GB0110682D0 (en)	2001-06-20
HUP0102816A2 (en)	2002-10-28
ES2192456B1 (en)	2005-02-01
PT102642B (en)	2003-06-30
ITMI20010009A0 (en)	2001-01-03
HRP20010345A2 (en)	2003-08-31
AT6141U1 (en)	2003-05-26
SK9572001A3 (en)	2003-03-04
GR20010100322A (en)	2002-10-08
ITMI20010009A1 (en)	2002-07-03
IE20010413A1 (en)	2003-04-16
HUP0102816A3 (en)	2005-01-28
FR2818907B1 (en)	2006-05-26
CZ20012464A3 (en)	2002-08-14
SK287043B6 (en)	2009-10-07
FR2818907A1 (en)	2002-07-05
GB2370771A (en)	2002-07-10
DK177084B1 (en)	2011-07-11
SE0102309L (en)	2002-07-04
HRPK20010345B3 (en)	2005-02-28
FI20011446A0 (en)	2001-07-03

Legal Events

Date	Code	Title	Description
2003-06-30	FG3A	Patent granted, date of granting	Effective date: 20030514

Publication	Publication Date	Title
ATE296619T1 (en)	2005-06-15	SOLID ORAL DOSAGE FORM OF SIMETHICON
PT1066027E (en)	2003-12-31	PHARMACEUTICAL COMPOSITION OF TOPIRAMATO
FI20011478A0 (en)	2001-07-05	Pharmaceutical composition
HK1070285A1 (en)	2005-06-17	Pharmaceutical dosage form of amorphous nelfinavirmesylate
IS6986A (en)	2003-10-09	Liquid pharmaceutical composition
PL367180A1 (en)	2005-02-21	Stabilized oral pharmaceutical composition
PT1235799E (en)	2005-05-31	POLYMORIC FORM OF ATORVASTATIN-CALCIUM
EE200200486A (en)	2004-02-16	Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and processes for their preparation
EE05020B1 (en)	2008-06-16	The pharmaceutical composition of G1buride
DK1458377T3 (en)	2006-06-12	Pharmaceutical compositions containing tegaserod
BRPI0209720A2 (en)	2017-06-13	dosage and packaging of controlled release medication
IS7051A (en)	2003-11-26	pharmaceutical compositions
DK1425005T3 (en)	2006-09-04	Pharmaceutical composition containing lumiracoxib
FI20022128A0 (en)	2002-12-03	Pharmaceutical composition
NO20021898D0 (en)	2002-04-22	Pharmaceutical composition containing ciclesonide for application to mucosa
ATE350016T1 (en)	2007-01-15	PHARMACEUTICAL COMPOSITION CONTAINING BICALUTAMID
EE200300468A (en)	2004-02-16	Stable pharmaceutical composition of pravastatin
LU90483B1 (en)	2001-01-31	New compositions of parox-tine m-thanesulfonate
HUP0401862A3 (en)	2009-03-30	Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them
PT102642A (en)	2002-07-31	PHARMACEUTICAL PHARMACEUTICAL COMPOSITION OF DAILY UNIQUE DOSAGE CONTAINING BRIVUDINE
ITBO20010005V0 (en)	2001-01-23	AUTOMATIC DISPENSER OF MEDICINAL PRODUCTS
ATE350029T1 (en)	2007-01-15	PHARMACEUTICAL COMPOSITION CONTAINING GAMMA-BUTYROBETAIN
NO20033073D0 (en)	2003-07-04	Pharmaceutical composition containing citalopram
ITMI20011284A0 (en)	2001-06-19	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERPHOSPHATEMIA
NO20042074L (en)	2004-05-19	Macrolides containing pharmaceutical compositions